This executive order establishes additional tariffs on Chinese imports as a response to what the order characterizes as the People's Republic of China's (PRC) failure to adequately address the synthetic opioid crisis affecting the United States. The order frames the influx of synthetic opioids as a national emergency killing approximately 200 Americans daily and identifies the PRC as playing a central role in this crisis by allegedly subsidizing and incentivizing chemical companies that export fentanyl precursors. It expands upon previous national emergency declarations related to border security and specifically charges that despite having sophisticated surveillance and law enforcement capabilities, the Chinese government has failed to cooperate in stemming the flow of precursor chemicals to cartels and shutting down money laundering operations by transnational criminal organizations (TCOs).
The order imposes an additional 10 percent ad valorem tariff on all products imported from China, effective February 4, 2025, with limited exceptions for goods already in transit before February 1, 2025. These duties will be applied in addition to existing tariffs, and the order explicitly eliminates duty-free de minimis treatment for affected Chinese products. The order also includes provisions allowing for potential increases or expansions of these duties if China retaliates with its own trade measures. Additionally, it requires that Chinese products entering U.S. foreign trade zones be admitted as "privileged foreign status," subjecting them to applicable duties upon entry into U.S. commerce.
Implementation of the order falls primarily to the Secretary of Homeland Security, who is directed to consult regularly with the Secretaries of State and Treasury, the Attorney General, and presidential advisors on national security and homeland security regarding China's actions. The Secretary is tasked with informing the President if China takes adequate steps to alleviate the opioid crisis through cooperative actions, which could lead to removal of the tariffs. The order also authorizes the Secretary of Homeland Security to recommend additional actions if China fails to cooperate sufficiently and to submit recurring reports to Congress on the national emergency. While presented as a targeted response to the opioid crisis, the broad application of tariffs across all Chinese imports represents a significant escalation in U.S.-China trade relations and economic policy.